nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A1—Dacarbazine—sarcoma	0.17	0.277	CbGbCtD
Pentamidine—CYP1A2—Dacarbazine—sarcoma	0.0761	0.124	CbGbCtD
Pentamidine—CYP3A4—Thiotepa—sarcoma	0.0719	0.117	CbGbCtD
Pentamidine—CYP3A5—Vincristine—sarcoma	0.0546	0.0889	CbGbCtD
Pentamidine—CYP3A5—Etoposide—sarcoma	0.05	0.0814	CbGbCtD
Pentamidine—CYP2C8—Etoposide—sarcoma	0.0481	0.0783	CbGbCtD
Pentamidine—CYP1A2—Etoposide—sarcoma	0.0372	0.0606	CbGbCtD
Pentamidine—CYP3A4—Mitoxantrone—sarcoma	0.0309	0.0504	CbGbCtD
Pentamidine—CYP3A4—Vincristine—sarcoma	0.0213	0.0347	CbGbCtD
Pentamidine—CYP2D6—Doxorubicin—sarcoma	0.0209	0.0341	CbGbCtD
Pentamidine—CYP3A4—Etoposide—sarcoma	0.0195	0.0318	CbGbCtD
Pentamidine—CYP3A4—Doxorubicin—sarcoma	0.0133	0.0217	CbGbCtD
Pentamidine—TRDMT1—hematopoietic system—sarcoma	0.0109	0.139	CbGeAlD
Pentamidine—TRDMT1—uterus—sarcoma	0.00827	0.105	CbGeAlD
Pentamidine—AOC1—embryo—sarcoma	0.00552	0.0703	CbGeAlD
Pentamidine—AOC1—hematopoietic system—sarcoma	0.00493	0.0628	CbGeAlD
Pentamidine—AOC1—connective tissue—sarcoma	0.00475	0.0605	CbGeAlD
Pentamidine—S100B—hematopoietic system—sarcoma	0.0043	0.0547	CbGeAlD
Pentamidine—S100B—connective tissue—sarcoma	0.00414	0.0527	CbGeAlD
Pentamidine—S100B—skin of body—sarcoma	0.00374	0.0476	CbGeAlD
Pentamidine—AOC1—bone marrow—sarcoma	0.00316	0.0403	CbGeAlD
Pentamidine—S100B—lymphoid tissue—sarcoma	0.00303	0.0385	CbGeAlD
Pentamidine—AOC1—testis—sarcoma	0.0027	0.0344	CbGeAlD
Pentamidine—AOC1—liver—sarcoma	0.00256	0.0325	CbGeAlD
Pentamidine—CYP4A11—liver—sarcoma	0.00212	0.027	CbGeAlD
Pentamidine—AOC1—lymph node—sarcoma	0.00196	0.0249	CbGeAlD
Pentamidine—S100B—lymph node—sarcoma	0.00171	0.0217	CbGeAlD
Pentamidine—CYP2C8—mammary gland—sarcoma	0.00165	0.021	CbGeAlD
Pentamidine—CYP2C19—hematopoietic system—sarcoma	0.00115	0.0147	CbGeAlD
Pentamidine—CYP2C8—hematopoietic system—sarcoma	0.00101	0.0128	CbGeAlD
Pentamidine—CYP1A2—hematopoietic system—sarcoma	0.000942	0.012	CbGeAlD
Pentamidine—CYP1A1—hematopoietic system—sarcoma	0.000929	0.0118	CbGeAlD
Pentamidine—CYP3A5—hematopoietic system—sarcoma	0.000909	0.0116	CbGeAlD
Pentamidine—CYP1A1—skin of body—sarcoma	0.000808	0.0103	CbGeAlD
Pentamidine—CYP1A1—cardiac atrium—sarcoma	0.000706	0.00898	CbGeAlD
Pentamidine—CYP1A1—uterus—sarcoma	0.000702	0.00894	CbGeAlD
Pentamidine—CYP3A4—hematopoietic system—sarcoma	0.000682	0.00868	CbGeAlD
Pentamidine—CYP2D6—hematopoietic system—sarcoma	0.000671	0.00854	CbGeAlD
Pentamidine—CYP2C19—liver—sarcoma	0.000597	0.00761	CbGeAlD
Pentamidine—CYP2C8—testis—sarcoma	0.000552	0.00702	CbGeAlD
Pentamidine—CYP2C8—liver—sarcoma	0.000522	0.00664	CbGeAlD
Pentamidine—CYP1A2—liver—sarcoma	0.000488	0.00621	CbGeAlD
Pentamidine—CYP1A1—liver—sarcoma	0.000481	0.00613	CbGeAlD
Pentamidine—CYP3A5—liver—sarcoma	0.000471	0.00599	CbGeAlD
Pentamidine—Fatigue—Vincristine—sarcoma	0.000392	0.0013	CcSEcCtD
Pentamidine—Convulsion—Etoposide—sarcoma	0.000391	0.00129	CcSEcCtD
Pentamidine—Dyspepsia—Mitoxantrone—sarcoma	0.00039	0.00129	CcSEcCtD
Pentamidine—Hypertension—Etoposide—sarcoma	0.00039	0.00129	CcSEcCtD
Pentamidine—Pain—Vincristine—sarcoma	0.000389	0.00129	CcSEcCtD
Pentamidine—Constipation—Vincristine—sarcoma	0.000389	0.00129	CcSEcCtD
Pentamidine—Liver function test abnormal—Epirubicin—sarcoma	0.000388	0.00128	CcSEcCtD
Pentamidine—Dry skin—Epirubicin—sarcoma	0.000385	0.00127	CcSEcCtD
Pentamidine—Decreased appetite—Mitoxantrone—sarcoma	0.000385	0.00127	CcSEcCtD
Pentamidine—Chest pain—Etoposide—sarcoma	0.000384	0.00127	CcSEcCtD
Pentamidine—Affect lability—Doxorubicin—sarcoma	0.000382	0.00127	CcSEcCtD
Pentamidine—Fatigue—Mitoxantrone—sarcoma	0.000382	0.00126	CcSEcCtD
Pentamidine—Discomfort—Etoposide—sarcoma	0.00038	0.00126	CcSEcCtD
Pentamidine—Constipation—Mitoxantrone—sarcoma	0.000379	0.00125	CcSEcCtD
Pentamidine—Pain—Mitoxantrone—sarcoma	0.000379	0.00125	CcSEcCtD
Pentamidine—Hypersensitivity—Thiotepa—sarcoma	0.000378	0.00125	CcSEcCtD
Pentamidine—Face oedema—Doxorubicin—sarcoma	0.000375	0.00124	CcSEcCtD
Pentamidine—Hypersensitivity—Dactinomycin—sarcoma	0.000375	0.00124	CcSEcCtD
Pentamidine—Gastrointestinal pain—Vincristine—sarcoma	0.000372	0.00123	CcSEcCtD
Pentamidine—Gastritis—Epirubicin—sarcoma	0.000372	0.00123	CcSEcCtD
Pentamidine—Confusional state—Etoposide—sarcoma	0.000371	0.00123	CcSEcCtD
Pentamidine—CYP1A1—lymph node—sarcoma	0.000369	0.0047	CbGeAlD
Pentamidine—AOC1—Tryptophan metabolism—MDM2—sarcoma	0.000369	0.0717	CbGpPWpGaD
Pentamidine—Anaphylactic shock—Etoposide—sarcoma	0.000368	0.00122	CcSEcCtD
Pentamidine—Mood swings—Doxorubicin—sarcoma	0.000368	0.00122	CcSEcCtD
Pentamidine—Asthenia—Thiotepa—sarcoma	0.000368	0.00122	CcSEcCtD
Pentamidine—CYP2D6—testis—sarcoma	0.000368	0.00468	CbGeAlD
Pentamidine—Infection—Etoposide—sarcoma	0.000366	0.00121	CcSEcCtD
Pentamidine—Asthenia—Dactinomycin—sarcoma	0.000365	0.00121	CcSEcCtD
Pentamidine—Feeling abnormal—Mitoxantrone—sarcoma	0.000365	0.00121	CcSEcCtD
Pentamidine—Blood creatinine increased—Doxorubicin—sarcoma	0.000364	0.0012	CcSEcCtD
Pentamidine—Asthma—Epirubicin—sarcoma	0.000363	0.0012	CcSEcCtD
Pentamidine—Influenza—Epirubicin—sarcoma	0.000363	0.0012	CcSEcCtD
Pentamidine—Pruritus—Thiotepa—sarcoma	0.000363	0.0012	CcSEcCtD
Pentamidine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000362	0.0012	CcSEcCtD
Pentamidine—Thrombocytopenia—Etoposide—sarcoma	0.000361	0.00119	CcSEcCtD
Pentamidine—Tachycardia—Etoposide—sarcoma	0.000359	0.00119	CcSEcCtD
Pentamidine—Eosinophilia—Epirubicin—sarcoma	0.000359	0.00119	CcSEcCtD
Pentamidine—Body temperature increased—Vincristine—sarcoma	0.000359	0.00119	CcSEcCtD
Pentamidine—Abdominal pain—Vincristine—sarcoma	0.000359	0.00119	CcSEcCtD
Pentamidine—Liver function test abnormal—Doxorubicin—sarcoma	0.000359	0.00119	CcSEcCtD
Pentamidine—Dry skin—Doxorubicin—sarcoma	0.000356	0.00118	CcSEcCtD
Pentamidine—Pancreatitis—Epirubicin—sarcoma	0.000356	0.00118	CcSEcCtD
Pentamidine—CYP3A4—liver—sarcoma	0.000353	0.0045	CbGeAlD
Pentamidine—Urticaria—Mitoxantrone—sarcoma	0.000352	0.00116	CcSEcCtD
Pentamidine—Anorexia—Etoposide—sarcoma	0.000351	0.00116	CcSEcCtD
Pentamidine—Diarrhoea—Thiotepa—sarcoma	0.000351	0.00116	CcSEcCtD
Pentamidine—Abdominal pain—Mitoxantrone—sarcoma	0.00035	0.00116	CcSEcCtD
Pentamidine—Body temperature increased—Mitoxantrone—sarcoma	0.00035	0.00116	CcSEcCtD
Pentamidine—Bronchitis—Epirubicin—sarcoma	0.000349	0.00115	CcSEcCtD
Pentamidine—Diarrhoea—Dactinomycin—sarcoma	0.000348	0.00115	CcSEcCtD
Pentamidine—CYP2D6—liver—sarcoma	0.000348	0.00443	CbGeAlD
Pentamidine—Pancytopenia—Epirubicin—sarcoma	0.000345	0.00114	CcSEcCtD
Pentamidine—Hypotension—Etoposide—sarcoma	0.000344	0.00114	CcSEcCtD
Pentamidine—Gastritis—Doxorubicin—sarcoma	0.000344	0.00114	CcSEcCtD
Pentamidine—Neutropenia—Epirubicin—sarcoma	0.000339	0.00112	CcSEcCtD
Pentamidine—Dizziness—Thiotepa—sarcoma	0.000339	0.00112	CcSEcCtD
Pentamidine—Influenza—Doxorubicin—sarcoma	0.000336	0.00111	CcSEcCtD
Pentamidine—Asthma—Doxorubicin—sarcoma	0.000336	0.00111	CcSEcCtD
Pentamidine—Hypersensitivity—Vincristine—sarcoma	0.000335	0.00111	CcSEcCtD
Pentamidine—Eosinophilia—Doxorubicin—sarcoma	0.000333	0.0011	CcSEcCtD
Pentamidine—Paraesthesia—Etoposide—sarcoma	0.000331	0.00109	CcSEcCtD
Pentamidine—Pancreatitis—Doxorubicin—sarcoma	0.000329	0.00109	CcSEcCtD
Pentamidine—Dyspnoea—Etoposide—sarcoma	0.000328	0.00109	CcSEcCtD
Pentamidine—Hyperglycaemia—Epirubicin—sarcoma	0.000327	0.00108	CcSEcCtD
Pentamidine—Somnolence—Etoposide—sarcoma	0.000327	0.00108	CcSEcCtD
Pentamidine—Hypersensitivity—Mitoxantrone—sarcoma	0.000326	0.00108	CcSEcCtD
Pentamidine—Asthenia—Vincristine—sarcoma	0.000326	0.00108	CcSEcCtD
Pentamidine—Vomiting—Thiotepa—sarcoma	0.000326	0.00108	CcSEcCtD
Pentamidine—Drowsiness—Epirubicin—sarcoma	0.000324	0.00107	CcSEcCtD
Pentamidine—Vomiting—Dactinomycin—sarcoma	0.000323	0.00107	CcSEcCtD
Pentamidine—Rash—Thiotepa—sarcoma	0.000323	0.00107	CcSEcCtD
Pentamidine—Bronchitis—Doxorubicin—sarcoma	0.000323	0.00107	CcSEcCtD
Pentamidine—Dermatitis—Thiotepa—sarcoma	0.000323	0.00107	CcSEcCtD
Pentamidine—Headache—Thiotepa—sarcoma	0.000321	0.00106	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000321	0.00106	CcSEcCtD
Pentamidine—Rash—Dactinomycin—sarcoma	0.000321	0.00106	CcSEcCtD
Pentamidine—Decreased appetite—Etoposide—sarcoma	0.00032	0.00106	CcSEcCtD
Pentamidine—Pancytopenia—Doxorubicin—sarcoma	0.000319	0.00106	CcSEcCtD
Pentamidine—Renal failure—Epirubicin—sarcoma	0.000318	0.00105	CcSEcCtD
Pentamidine—Asthenia—Mitoxantrone—sarcoma	0.000318	0.00105	CcSEcCtD
Pentamidine—Fatigue—Etoposide—sarcoma	0.000317	0.00105	CcSEcCtD
Pentamidine—Neuropathy peripheral—Epirubicin—sarcoma	0.000317	0.00105	CcSEcCtD
Pentamidine—Stomatitis—Epirubicin—sarcoma	0.000315	0.00104	CcSEcCtD
Pentamidine—Pain—Etoposide—sarcoma	0.000315	0.00104	CcSEcCtD
Pentamidine—Constipation—Etoposide—sarcoma	0.000315	0.00104	CcSEcCtD
Pentamidine—Conjunctivitis—Epirubicin—sarcoma	0.000315	0.00104	CcSEcCtD
Pentamidine—Neutropenia—Doxorubicin—sarcoma	0.000314	0.00104	CcSEcCtD
Pentamidine—Diarrhoea—Vincristine—sarcoma	0.000311	0.00103	CcSEcCtD
Pentamidine—Haematuria—Epirubicin—sarcoma	0.000309	0.00102	CcSEcCtD
Pentamidine—Nausea—Thiotepa—sarcoma	0.000305	0.00101	CcSEcCtD
Pentamidine—Sinusitis—Epirubicin—sarcoma	0.000304	0.001	CcSEcCtD
Pentamidine—Feeling abnormal—Etoposide—sarcoma	0.000303	0.001	CcSEcCtD
Pentamidine—Hyperglycaemia—Doxorubicin—sarcoma	0.000303	0.001	CcSEcCtD
Pentamidine—Diarrhoea—Mitoxantrone—sarcoma	0.000303	0.001	CcSEcCtD
Pentamidine—Nausea—Dactinomycin—sarcoma	0.000302	0.001	CcSEcCtD
Pentamidine—Gastrointestinal pain—Etoposide—sarcoma	0.000301	0.000996	CcSEcCtD
Pentamidine—Dizziness—Vincristine—sarcoma	0.000301	0.000994	CcSEcCtD
Pentamidine—Drowsiness—Doxorubicin—sarcoma	0.000299	0.000991	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000297	0.000982	CcSEcCtD
Pentamidine—Bradycardia—Epirubicin—sarcoma	0.000296	0.000978	CcSEcCtD
Pentamidine—Renal failure—Doxorubicin—sarcoma	0.000294	0.000974	CcSEcCtD
Pentamidine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000294	0.000971	CcSEcCtD
Pentamidine—Urticaria—Etoposide—sarcoma	0.000293	0.000968	CcSEcCtD
Pentamidine—Stomatitis—Doxorubicin—sarcoma	0.000292	0.000966	CcSEcCtD
Pentamidine—Rhinitis—Epirubicin—sarcoma	0.000291	0.000964	CcSEcCtD
Pentamidine—Abdominal pain—Etoposide—sarcoma	0.000291	0.000963	CcSEcCtD
Pentamidine—Body temperature increased—Etoposide—sarcoma	0.000291	0.000963	CcSEcCtD
Pentamidine—Conjunctivitis—Doxorubicin—sarcoma	0.000291	0.000963	CcSEcCtD
Pentamidine—Hepatitis—Epirubicin—sarcoma	0.000291	0.000961	CcSEcCtD
Pentamidine—Hypoaesthesia—Epirubicin—sarcoma	0.000289	0.000956	CcSEcCtD
Pentamidine—Vomiting—Vincristine—sarcoma	0.000289	0.000956	CcSEcCtD
Pentamidine—Pharyngitis—Epirubicin—sarcoma	0.000288	0.000954	CcSEcCtD
Pentamidine—Rash—Vincristine—sarcoma	0.000287	0.000948	CcSEcCtD
Pentamidine—Dermatitis—Vincristine—sarcoma	0.000286	0.000947	CcSEcCtD
Pentamidine—Oedema peripheral—Epirubicin—sarcoma	0.000286	0.000947	CcSEcCtD
Pentamidine—Haematuria—Doxorubicin—sarcoma	0.000286	0.000944	CcSEcCtD
Pentamidine—Headache—Vincristine—sarcoma	0.000285	0.000942	CcSEcCtD
Pentamidine—Vomiting—Mitoxantrone—sarcoma	0.000281	0.000931	CcSEcCtD
Pentamidine—Sinusitis—Doxorubicin—sarcoma	0.000281	0.000929	CcSEcCtD
Pentamidine—Rash—Mitoxantrone—sarcoma	0.000279	0.000923	CcSEcCtD
Pentamidine—Dermatitis—Mitoxantrone—sarcoma	0.000279	0.000922	CcSEcCtD
Pentamidine—Headache—Mitoxantrone—sarcoma	0.000277	0.000917	CcSEcCtD
Pentamidine—Erythema multiforme—Epirubicin—sarcoma	0.000275	0.000909	CcSEcCtD
Pentamidine—Bradycardia—Doxorubicin—sarcoma	0.000274	0.000905	CcSEcCtD
Pentamidine—Hypersensitivity—Etoposide—sarcoma	0.000271	0.000897	CcSEcCtD
Pentamidine—Nausea—Vincristine—sarcoma	0.00027	0.000893	CcSEcCtD
Pentamidine—Flushing—Epirubicin—sarcoma	0.00027	0.000892	CcSEcCtD
Pentamidine—Rhinitis—Doxorubicin—sarcoma	0.00027	0.000892	CcSEcCtD
Pentamidine—Hepatitis—Doxorubicin—sarcoma	0.000269	0.000889	CcSEcCtD
Pentamidine—Hypoaesthesia—Doxorubicin—sarcoma	0.000267	0.000885	CcSEcCtD
Pentamidine—Pharyngitis—Doxorubicin—sarcoma	0.000267	0.000883	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—sarcoma	0.000265	0.000876	CcSEcCtD
Pentamidine—Asthenia—Etoposide—sarcoma	0.000264	0.000874	CcSEcCtD
Pentamidine—Nausea—Mitoxantrone—sarcoma	0.000263	0.00087	CcSEcCtD
Pentamidine—Chills—Epirubicin—sarcoma	0.000261	0.000862	CcSEcCtD
Pentamidine—Pruritus—Etoposide—sarcoma	0.000261	0.000862	CcSEcCtD
Pentamidine—Arrhythmia—Epirubicin—sarcoma	0.00026	0.000859	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—sarcoma	0.000254	0.000841	CcSEcCtD
Pentamidine—Erythema—Epirubicin—sarcoma	0.000253	0.000837	CcSEcCtD
Pentamidine—Diarrhoea—Etoposide—sarcoma	0.000252	0.000833	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—sarcoma	0.000249	0.000825	CcSEcCtD
Pentamidine—Tension—Epirubicin—sarcoma	0.000248	0.000821	CcSEcCtD
Pentamidine—Dysgeusia—Epirubicin—sarcoma	0.000248	0.000819	CcSEcCtD
Pentamidine—Nervousness—Epirubicin—sarcoma	0.000246	0.000813	CcSEcCtD
Pentamidine—Dizziness—Etoposide—sarcoma	0.000244	0.000805	CcSEcCtD
Pentamidine—Chills—Doxorubicin—sarcoma	0.000241	0.000798	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—sarcoma	0.00024	0.000794	CcSEcCtD
Pentamidine—Vision blurred—Epirubicin—sarcoma	0.000238	0.000788	CcSEcCtD
Pentamidine—Vomiting—Etoposide—sarcoma	0.000234	0.000774	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—sarcoma	0.000234	0.000774	CcSEcCtD
Pentamidine—Anaemia—Epirubicin—sarcoma	0.000234	0.000773	CcSEcCtD
Pentamidine—Rash—Etoposide—sarcoma	0.000232	0.000768	CcSEcCtD
Pentamidine—Dermatitis—Etoposide—sarcoma	0.000232	0.000767	CcSEcCtD
Pentamidine—Headache—Etoposide—sarcoma	0.000231	0.000763	CcSEcCtD
Pentamidine—Tension—Doxorubicin—sarcoma	0.00023	0.00076	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—sarcoma	0.000229	0.000758	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—sarcoma	0.000227	0.000752	CcSEcCtD
Pentamidine—Vertigo—Epirubicin—sarcoma	0.000227	0.000752	CcSEcCtD
Pentamidine—Syncope—Epirubicin—sarcoma	0.000227	0.00075	CcSEcCtD
Pentamidine—Leukopenia—Epirubicin—sarcoma	0.000226	0.000749	CcSEcCtD
Pentamidine—Palpitations—Epirubicin—sarcoma	0.000224	0.000739	CcSEcCtD
Pentamidine—Loss of consciousness—Epirubicin—sarcoma	0.000222	0.000735	CcSEcCtD
Pentamidine—Cough—Epirubicin—sarcoma	0.000221	0.00073	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—sarcoma	0.000221	0.00073	CcSEcCtD
Pentamidine—Convulsion—Epirubicin—sarcoma	0.000219	0.000725	CcSEcCtD
Pentamidine—Nausea—Etoposide—sarcoma	0.000219	0.000724	CcSEcCtD
Pentamidine—Hypertension—Epirubicin—sarcoma	0.000218	0.000722	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—sarcoma	0.000216	0.000715	CcSEcCtD
Pentamidine—Chest pain—Epirubicin—sarcoma	0.000215	0.000712	CcSEcCtD
Pentamidine—Myalgia—Epirubicin—sarcoma	0.000215	0.000712	CcSEcCtD
Pentamidine—Arthralgia—Epirubicin—sarcoma	0.000215	0.000712	CcSEcCtD
Pentamidine—Anxiety—Epirubicin—sarcoma	0.000215	0.00071	CcSEcCtD
Pentamidine—Discomfort—Epirubicin—sarcoma	0.000213	0.000704	CcSEcCtD
Pentamidine—Dry mouth—Epirubicin—sarcoma	0.000211	0.000697	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—sarcoma	0.00021	0.000695	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—sarcoma	0.00021	0.000694	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—sarcoma	0.000209	0.000693	CcSEcCtD
Pentamidine—Confusional state—Epirubicin—sarcoma	0.000208	0.000688	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—sarcoma	0.000207	0.000684	CcSEcCtD
Pentamidine—Anaphylactic shock—Epirubicin—sarcoma	0.000206	0.000683	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—sarcoma	0.000206	0.00068	CcSEcCtD
Pentamidine—Infection—Epirubicin—sarcoma	0.000205	0.000678	CcSEcCtD
Pentamidine—Cough—Doxorubicin—sarcoma	0.000204	0.000676	CcSEcCtD
Pentamidine—Shock—Epirubicin—sarcoma	0.000203	0.000672	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—sarcoma	0.000203	0.000671	CcSEcCtD
Pentamidine—Thrombocytopenia—Epirubicin—sarcoma	0.000202	0.000669	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—sarcoma	0.000202	0.000668	CcSEcCtD
Pentamidine—Tachycardia—Epirubicin—sarcoma	0.000201	0.000666	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—sarcoma	0.000199	0.000659	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—sarcoma	0.000199	0.000659	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—sarcoma	0.000199	0.000659	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—sarcoma	0.000199	0.000657	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—sarcoma	0.000197	0.000651	CcSEcCtD
Pentamidine—Anorexia—Epirubicin—sarcoma	0.000197	0.000651	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—sarcoma	0.000195	0.000645	CcSEcCtD
Pentamidine—Hypotension—Epirubicin—sarcoma	0.000193	0.000638	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—sarcoma	0.000193	0.000637	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—sarcoma	0.000191	0.000632	CcSEcCtD
Pentamidine—Infection—Doxorubicin—sarcoma	0.00019	0.000628	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000188	0.000622	CcSEcCtD
Pentamidine—Shock—Doxorubicin—sarcoma	0.000188	0.000622	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—sarcoma	0.000187	0.000619	CcSEcCtD
Pentamidine—Insomnia—Epirubicin—sarcoma	0.000187	0.000618	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—sarcoma	0.000186	0.000617	CcSEcCtD
Pentamidine—Paraesthesia—Epirubicin—sarcoma	0.000185	0.000613	CcSEcCtD
Pentamidine—Dyspnoea—Epirubicin—sarcoma	0.000184	0.000609	CcSEcCtD
Pentamidine—Somnolence—Epirubicin—sarcoma	0.000184	0.000607	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—sarcoma	0.000182	0.000602	CcSEcCtD
Pentamidine—Dyspepsia—Epirubicin—sarcoma	0.000182	0.000601	CcSEcCtD
Pentamidine—Decreased appetite—Epirubicin—sarcoma	0.000179	0.000594	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—sarcoma	0.000178	0.00059	CcSEcCtD
Pentamidine—Fatigue—Epirubicin—sarcoma	0.000178	0.000589	CcSEcCtD
Pentamidine—Constipation—Epirubicin—sarcoma	0.000177	0.000584	CcSEcCtD
Pentamidine—Pain—Epirubicin—sarcoma	0.000177	0.000584	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000174	0.000576	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—sarcoma	0.000173	0.000571	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—sarcoma	0.000172	0.000567	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—sarcoma	0.00017	0.000563	CcSEcCtD
Pentamidine—Feeling abnormal—Epirubicin—sarcoma	0.00017	0.000563	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—sarcoma	0.00017	0.000562	CcSEcCtD
Pentamidine—Gastrointestinal pain—Epirubicin—sarcoma	0.000169	0.000558	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—sarcoma	0.000168	0.000556	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—sarcoma	0.000166	0.000549	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—sarcoma	0.000165	0.000545	CcSEcCtD
Pentamidine—Urticaria—Epirubicin—sarcoma	0.000164	0.000542	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—sarcoma	0.000163	0.00054	CcSEcCtD
Pentamidine—Pain—Doxorubicin—sarcoma	0.000163	0.00054	CcSEcCtD
Pentamidine—Abdominal pain—Epirubicin—sarcoma	0.000163	0.00054	CcSEcCtD
Pentamidine—Body temperature increased—Epirubicin—sarcoma	0.000163	0.00054	CcSEcCtD
Pentamidine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—ATF1—sarcoma	0.000159	0.0309	CbGpPWpGaD
Pentamidine—Feeling abnormal—Doxorubicin—sarcoma	0.000157	0.000521	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000156	0.000517	CcSEcCtD
Pentamidine—Hypersensitivity—Epirubicin—sarcoma	0.000152	0.000503	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—sarcoma	0.000152	0.000502	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—sarcoma	0.000151	0.000499	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—sarcoma	0.000151	0.000499	CcSEcCtD
Pentamidine—Asthenia—Epirubicin—sarcoma	0.000148	0.00049	CcSEcCtD
Pentamidine—Pruritus—Epirubicin—sarcoma	0.000146	0.000483	CcSEcCtD
Pentamidine—S100B—MyD88 cascade initiated on plasma membrane—ATF1—sarcoma	0.000144	0.0279	CbGpPWpGaD
Pentamidine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—sarcoma	0.000142	0.0277	CbGpPWpGaD
Pentamidine—Diarrhoea—Epirubicin—sarcoma	0.000141	0.000467	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—sarcoma	0.000141	0.000465	CcSEcCtD
Pentamidine—S100B—MyD88 dependent cascade initiated on endosome—ATF1—sarcoma	0.00014	0.0272	CbGpPWpGaD
Pentamidine—Asthenia—Doxorubicin—sarcoma	0.000137	0.000453	CcSEcCtD
Pentamidine—Dizziness—Epirubicin—sarcoma	0.000136	0.000452	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—sarcoma	0.000135	0.000447	CcSEcCtD
Pentamidine—S100B—Toll Like Receptor 9 (TLR9) Cascade—ATF1—sarcoma	0.000135	0.0262	CbGpPWpGaD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—ATF1—sarcoma	0.000132	0.0258	CbGpPWpGaD
Pentamidine—Vomiting—Epirubicin—sarcoma	0.000131	0.000434	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—sarcoma	0.000131	0.000432	CcSEcCtD
Pentamidine—Rash—Epirubicin—sarcoma	0.00013	0.000431	CcSEcCtD
Pentamidine—CYP4A11—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.00013	0.0253	CbGpPWpGaD
Pentamidine—Dermatitis—Epirubicin—sarcoma	0.00013	0.00043	CcSEcCtD
Pentamidine—Headache—Epirubicin—sarcoma	0.000129	0.000428	CcSEcCtD
Pentamidine—S100B—MyD88-independent cascade—ATF1—sarcoma	0.000127	0.0247	CbGpPWpGaD
Pentamidine—Dizziness—Doxorubicin—sarcoma	0.000126	0.000418	CcSEcCtD
Pentamidine—Nausea—Epirubicin—sarcoma	0.000123	0.000406	CcSEcCtD
Pentamidine—Vomiting—Doxorubicin—sarcoma	0.000121	0.000402	CcSEcCtD
Pentamidine—Rash—Doxorubicin—sarcoma	0.00012	0.000398	CcSEcCtD
Pentamidine—Dermatitis—Doxorubicin—sarcoma	0.00012	0.000398	CcSEcCtD
Pentamidine—Headache—Doxorubicin—sarcoma	0.00012	0.000396	CcSEcCtD
Pentamidine—S100B—Activated TLR4 signalling—ATF1—sarcoma	0.000114	0.0222	CbGpPWpGaD
Pentamidine—Nausea—Doxorubicin—sarcoma	0.000113	0.000375	CcSEcCtD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—ATF1—sarcoma	0.000108	0.0209	CbGpPWpGaD
Pentamidine—S100B—Toll-Like Receptors Cascades—ATF1—sarcoma	9.58e-05	0.0186	CbGpPWpGaD
Pentamidine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—CREB1—sarcoma	8.6e-05	0.0167	CbGpPWpGaD
Pentamidine—CYP4A11—PPAR Alpha Pathway—CCND1—sarcoma	8.03e-05	0.0156	CbGpPWpGaD
Pentamidine—S100B—MyD88 cascade initiated on plasma membrane—CREB1—sarcoma	7.78e-05	0.0151	CbGpPWpGaD
Pentamidine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CREB1—sarcoma	7.71e-05	0.015	CbGpPWpGaD
Pentamidine—S100B—MyD88 dependent cascade initiated on endosome—CREB1—sarcoma	7.56e-05	0.0147	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 9 (TLR9) Cascade—CREB1—sarcoma	7.3e-05	0.0142	CbGpPWpGaD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—CREB1—sarcoma	7.18e-05	0.014	CbGpPWpGaD
Pentamidine—S100B—MyD88-independent cascade—CREB1—sarcoma	6.88e-05	0.0134	CbGpPWpGaD
Pentamidine—S100B—Cytosolic sensors of pathogen-associated DNA—CTNNB1—sarcoma	6.8e-05	0.0132	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—FOXO1—sarcoma	6.74e-05	0.0131	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—PDGFRB—sarcoma	6.72e-05	0.0131	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—PDGFRA—sarcoma	6.62e-05	0.0129	CbGpPWpGaD
Pentamidine—CYP4A11—PPAR Alpha Pathway—MYC—sarcoma	6.44e-05	0.0125	CbGpPWpGaD
Pentamidine—S100B—Activated TLR4 signalling—CREB1—sarcoma	6.19e-05	0.012	CbGpPWpGaD
Pentamidine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—JUN—sarcoma	6.18e-05	0.012	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—CREB1—sarcoma	5.82e-05	0.0113	CbGpPWpGaD
Pentamidine—S100B—MyD88 cascade initiated on plasma membrane—JUN—sarcoma	5.59e-05	0.0109	CbGpPWpGaD
Pentamidine—CYP1A1—Melatonin metabolism and effects—FOXO1—sarcoma	5.59e-05	0.0109	CbGpPWpGaD
Pentamidine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—sarcoma	5.54e-05	0.0108	CbGpPWpGaD
Pentamidine—CYP1A1—Estrogen Receptor Pathway—JUN—sarcoma	5.54e-05	0.0108	CbGpPWpGaD
Pentamidine—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	5.47e-05	0.0106	CbGpPWpGaD
Pentamidine—S100B—MyD88 dependent cascade initiated on endosome—JUN—sarcoma	5.44e-05	0.0106	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 9 (TLR9) Cascade—JUN—sarcoma	5.25e-05	0.0102	CbGpPWpGaD
Pentamidine—S100B—Toll-Like Receptors Cascades—CREB1—sarcoma	5.19e-05	0.0101	CbGpPWpGaD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—JUN—sarcoma	5.16e-05	0.01	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—KIT—sarcoma	5.13e-05	0.00998	CbGpPWpGaD
Pentamidine—S100B—MyD88-independent cascade—JUN—sarcoma	4.95e-05	0.00963	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—CREB1—sarcoma	4.89e-05	0.0095	CbGpPWpGaD
Pentamidine—CYP2C19—Melatonin metabolism and effects—FOXO1—sarcoma	4.57e-05	0.00889	CbGpPWpGaD
Pentamidine—S100B—Activated TLR4 signalling—JUN—sarcoma	4.45e-05	0.00866	CbGpPWpGaD
Pentamidine—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	4.23e-05	0.00822	CbGpPWpGaD
Pentamidine—CYP2D6—Melatonin metabolism and effects—FOXO1—sarcoma	4.21e-05	0.00818	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—JUN—sarcoma	4.19e-05	0.00815	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—MDM2—sarcoma	4.04e-05	0.00786	CbGpPWpGaD
Pentamidine—S100B—Toll-Like Receptors Cascades—JUN—sarcoma	3.73e-05	0.00725	CbGpPWpGaD
Pentamidine—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	3.56e-05	0.00693	CbGpPWpGaD
Pentamidine—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	3.53e-05	0.00687	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PLCG1—sarcoma	3.27e-05	0.00635	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—ATF1—sarcoma	3.1e-05	0.00603	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—NRAS—sarcoma	3.03e-05	0.0059	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—EGFR—sarcoma	2.76e-05	0.00537	CbGpPWpGaD
Pentamidine—S100B—Immune System—CD34—sarcoma	2.69e-05	0.00523	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—KRAS—sarcoma	2.61e-05	0.00507	CbGpPWpGaD
Pentamidine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	2.54e-05	0.00494	CbGpPWpGaD
Pentamidine—CYP1A1—Tryptophan metabolism—MDM2—sarcoma	2.32e-05	0.00451	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—FOXO1—sarcoma	2.32e-05	0.00451	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PDGFRB—sarcoma	2.31e-05	0.0045	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PDGFRA—sarcoma	2.28e-05	0.00443	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—HRAS—sarcoma	2.22e-05	0.00431	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	2.07e-05	0.00403	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	2.02e-05	0.00392	CbGpPWpGaD
Pentamidine—S100B—Immune System—PTPRC—sarcoma	1.94e-05	0.00378	CbGpPWpGaD
Pentamidine—S100B—Immune System—PLCG1—sarcoma	1.9e-05	0.0037	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TLE1—sarcoma	1.85e-05	0.00361	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	1.81e-05	0.00351	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—SRC—sarcoma	1.81e-05	0.00351	CbGpPWpGaD
Pentamidine—S100B—Immune System—ATF1—sarcoma	1.81e-05	0.00351	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—KIT—sarcoma	1.77e-05	0.00343	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	1.76e-05	0.00342	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	1.74e-05	0.00338	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CREB1—sarcoma	1.68e-05	0.00327	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—sarcoma	1.62e-05	0.00315	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	1.58e-05	0.00308	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	1.58e-05	0.00308	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFC—sarcoma	1.56e-05	0.00304	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	1.5e-05	0.00291	CbGpPWpGaD
Pentamidine—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	1.48e-05	0.00287	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—MDM2—sarcoma	1.39e-05	0.0027	CbGpPWpGaD
Pentamidine—S100B—Immune System—FOXO1—sarcoma	1.35e-05	0.00262	CbGpPWpGaD
Pentamidine—S100B—Immune System—PDGFRB—sarcoma	1.35e-05	0.00262	CbGpPWpGaD
Pentamidine—S100B—Immune System—PDGFRA—sarcoma	1.33e-05	0.00258	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	1.32e-05	0.00257	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	1.28e-05	0.0025	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	1.27e-05	0.00247	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—FLT1—sarcoma	1.25e-05	0.00243	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PLCG1—sarcoma	1.23e-05	0.00239	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—JUN—sarcoma	1.21e-05	0.00235	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CTNNB1—sarcoma	1.2e-05	0.00233	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCR4—sarcoma	1.18e-05	0.0023	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ATF1—sarcoma	1.17e-05	0.00227	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	1.15e-05	0.00224	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	1.15e-05	0.00224	CbGpPWpGaD
Pentamidine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	1.14e-05	0.00222	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	1.12e-05	0.00218	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	1.11e-05	0.00216	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—SRC—sarcoma	1.08e-05	0.00211	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—NRAS—sarcoma	1.04e-05	0.00203	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	1.03e-05	0.00201	CbGpPWpGaD
Pentamidine—S100B—Immune System—KIT—sarcoma	1.03e-05	0.002	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	1.01e-05	0.00196	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	1.01e-05	0.00196	CbGpPWpGaD
Pentamidine—S100B—Immune System—CREB1—sarcoma	9.79e-06	0.0019	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ENO2—sarcoma	9.63e-06	0.00187	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—HBA1—sarcoma	9.57e-06	0.00186	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	9.54e-06	0.00186	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—EGFR—sarcoma	9.5e-06	0.00185	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IGF1R—sarcoma	9.17e-06	0.00178	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—KRAS—sarcoma	8.98e-06	0.00175	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—FOXO1—sarcoma	8.73e-06	0.0017	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PDGFRB—sarcoma	8.71e-06	0.00169	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PDGFRA—sarcoma	8.57e-06	0.00167	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PLCG1—sarcoma	8.17e-06	0.00159	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	8.11e-06	0.00158	CbGpPWpGaD
Pentamidine—S100B—Immune System—MDM2—sarcoma	8.1e-06	0.00157	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—HRAS—sarcoma	7.63e-06	0.00148	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL2—sarcoma	7.24e-06	0.00141	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KDR—sarcoma	7.22e-06	0.0014	CbGpPWpGaD
Pentamidine—S100B—Immune System—JUN—sarcoma	7.04e-06	0.00137	CbGpPWpGaD
Pentamidine—S100B—Immune System—CTNNB1—sarcoma	6.99e-06	0.00136	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KIT—sarcoma	6.65e-06	0.00129	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CREB1—sarcoma	6.33e-06	0.00123	CbGpPWpGaD
Pentamidine—S100B—Immune System—SRC—sarcoma	6.31e-06	0.00123	CbGpPWpGaD
Pentamidine—S100B—Immune System—NRAS—sarcoma	6.07e-06	0.00118	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGFR—sarcoma	5.53e-06	0.00108	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MDM2—sarcoma	5.24e-06	0.00102	CbGpPWpGaD
Pentamidine—S100B—Immune System—KRAS—sarcoma	5.23e-06	0.00102	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2—sarcoma	4.68e-06	0.00091	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCND1—sarcoma	4.56e-06	0.000887	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—JUN—sarcoma	4.55e-06	0.000885	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CTNNB1—sarcoma	4.52e-06	0.000878	CbGpPWpGaD
Pentamidine—S100B—Immune System—HRAS—sarcoma	4.44e-06	0.000864	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SRC—sarcoma	4.08e-06	0.000794	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ENO2—sarcoma	4.04e-06	0.000786	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HBA1—sarcoma	4.02e-06	0.000781	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—sarcoma	3.98e-06	0.000773	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NRAS—sarcoma	3.93e-06	0.000764	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ENO2—sarcoma	3.82e-06	0.000743	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HBA1—sarcoma	3.8e-06	0.000738	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—sarcoma	3.66e-06	0.000711	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—sarcoma	3.58e-06	0.000696	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ENO2—sarcoma	3.5e-06	0.000681	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HBA1—sarcoma	3.48e-06	0.000677	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PLCG1—sarcoma	3.43e-06	0.000667	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KRAS—sarcoma	3.38e-06	0.000657	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PLCG1—sarcoma	3.24e-06	0.00063	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ENO2—sarcoma	3.13e-06	0.000608	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HBA1—sarcoma	3.11e-06	0.000604	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—sarcoma	3e-06	0.000584	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PLCG1—sarcoma	2.97e-06	0.000578	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ENO2—sarcoma	2.88e-06	0.000559	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—sarcoma	2.87e-06	0.000559	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HBA1—sarcoma	2.86e-06	0.000556	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PLCG1—sarcoma	2.65e-06	0.000516	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PLCG1—sarcoma	2.44e-06	0.000474	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ENO2—sarcoma	2.44e-06	0.000474	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HBA1—sarcoma	2.42e-06	0.000471	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PLCG1—sarcoma	2.07e-06	0.000402	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ENO2—sarcoma	1.88e-06	0.000366	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HBA1—sarcoma	1.87e-06	0.000363	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PLCG1—sarcoma	1.6e-06	0.00031	CbGpPWpGaD
